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Abstract 
Methyl 2-benzimidazole carbamate (carbendazim) is one of the synthetic 
fungicides that controlled organisms that caused plant diseases of different 
types. It is widely used as a preservative in leather, paint, textile, fruits and 
papermaking industry. It is also used as an anticancer drug in chemical 
medicine. In the present study low concentrations of carbendazim was 
administered at 5, 10, 25 and 50mM doses intradermally to male albino rats. 
At the end of 6 hr, 12hr and 24hr duration, blood samples were collected 
from the animal for the analysis of biochemical and haematological 
parameters. Carbendazim caused an increase of cholesterol, uric acid, glucose 
and creatinine while serum phosphorous content was decreased. However, 
mean hemoglobin, WBC, E, and platelet counts increased and total RBC, N 
and L counts decreased. These results indicated that low dose level 
carbendazim contributed to toxicological effects in the rat tissues. 
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Introduction  
Pollutants in the environment cause various hazards 
directly on living species. Most environmental 
pollutants are chemical pesticides. Carbendazim, a 
broad spectrum benzimidazole carbamate fungicide 
with systemic activity is used against various degrees 
of fungal disease in field crops, fruits, ornamental 
plants and vegetables. On the other hand, 
carbendazim is noted to have toxic effects on a 
variety of experimental animals. The fungicidal 
properties of carbendazim has been identified as due 
to the binding of carbendazim to tubulins, an effect 
that distrupted microtubule formation and mitosis [1]. 
It was reported that in human granulosa cells, 
carbendazim had an antimitotic effect by interfering 
with microtubule and centrosome organization during 
mitosis [2]. Dietary administration of carbendazim for 
upto  90 days  produced  minimal  effects  on the liver  
 
weight in female rats exposed to 360mg/kg per day 
[3]. Carbendazim induced haematological, bioche-
mical and histopathological changes to liver and 
kidney of male rats when administered orally at 0, 
150, 300 and 600 mg/kg/ day for 15 weeks [4]. Yet, 
carbendazim was used widely to prevent and control 
plant diseases caused by fungi. The present study was 
therefore designed to investigate the low dose 
toxicological profile of carbendazim in the brain, 
heart, liver, kidney and testicular tissues of male rat. 
 
Materials and methods 
Animals 
Male albino wistar rats (180-200gm weighing) were 
obtained from the animal house JIPMER, Puducherry. 
Rats were divided into five groups, each containing 
six animals. One of the groups was control and the 
 doi:10.5138/ijdd.2010.0975.0215.02048 
©arjournals.org, All rights reserved. 
Muthuviveganandavel et al. International Journal of Drug Delivery 2 (2010) 352-356 
 353
other four were treatment groups. All the animals 
were kept under controlled conditions of temperature 
(22±10°C) and humidity (60±5°). They were given 
pellet food and drinking water ad libitum. A twelve 
hour day and night cycle was maintained in the 
animal house. 
 
Test substance 
Carbendazim (>96% pure) technical grade was 
obtained from Gharda Chemicals Ltd, Mumbai. 
 
Experimental design 
This study was four performed according to good 
laboratory practices. Rats were divided into a control 
and test groups, each group containing six animals. 
Carbendazim dissolved in ethanol was administered 
intradermally (5mM, 10mM, 25mM and 50mM) to 
the different groups at 6hr, 12hr and 24hr duration. 
All rats were given diethyl ether as an anaesthetic. 
Approximately 3 ml of blood was collected for 
hematological and clinical and biochemical 
evaluation. An additional one milliliter of blood was 
collected into EDTA coated tubes determination of 
hemoglobin (HB) content, erythrocyte (RBC), total 
leucocyte (WBC), differential leucocytes (N, E, L) 
and platelet counts.  
Two milliliter of blood were processed to obtain 
serum that was immediately frozen on dry ice and 
centrifuged at 5000 rpm for 10 minutes, and used 
subsequently for the quantitative determination of the 
following was carried out for cholesterol by the 
method of Zaks et al [5], urea by Natelson et al, [6], 
uric acid by Caraway [7], glucose by Asatoor and 
King [8], albumin by  Reinhold [9], creatinine by 
Owen et al, [10], calcium by Gitelman [11] and 
phosphorous  by Goldenberg [12].  
 
Statistical analysis 
An analysis of variance test (ANOVA) was used to 
evaluate the hematological and biochemical data for 
each measurement taken, and statistical significance 
(p<0.05 and p<0.01) was followed by a comparison 
of the group using Dunnett’s test. 
 
Result 
Biochemical studies 
Serum (Table 1) total protein content significantly 
decreased (p<0.01) at 6hr, 12hr and 24hr for all doses 
of carbendazim, while for the 25mM dose at 6hr, it 
was increased and no significant changes in protein 
was noted for the 25mM and 50mM doses. 
Cholesterol level was significantly (p<0.01) increased 
in a dose related manner at 24hr duration. Urea level 
was significantly decreased by 10mM dose at 12hrs 
and by 10mM and 50mM doses at 24hrs. The level of 
uric acid increased statistically significant (p<0.01) at 
6 hr, 12 hr and 24 hr in a dose related manner. Serum 
glucose level was significantly increased (p<0.01) by 
the low dose of 5mM and the high dose of 50mM at 
6hr, by 50mM at 12hr and by all doses at 24 hr. The 
doses of 10mM and 25mM at 6hr, and 5, 10 and 
25mM at 12 hr significantly decreased the serum 
glucose level in the rat. Albumin amount was 
decreased significantly by the low dose of 5mM but 
increased for 10mM dose at 6hr. The dose of 25mM 
significantly decreased albumin at 12hr. Similarly, at 
24hr, the doses of 10mM, 25mM and 50mM 
significantly decreased, whereas at low dose 
significantly (p<0.01) increased the serum albumin. 
Creatinine level in rat serum generally increased 
significantly for all doses and at all durations, except 
for high dose at 6 hr and 25mM at 12hr. Calcium 
level in rat serum at 6 hr showed increase at all doses 
of carbendazim. Although, significant decrease was 
seen for 5mM, 10mM and 50mM dose at 12hr and 24 
hr, the 25mM dose at 24 hr showed significant 
increase. Phosphorous level increased significantly at 
the low dose of 5mM at 12 hr and 24 hr time point 
and similarly at the high dose of 50mM showed 
statistically significant increase of serum phosphorous 
at 6 hr and 24 hr.  
 
Hematology 
Results of the hematological studies are shown in 
table 2. The mean concentration of hemoglobin 
significantly increased at 6hr, 12hr and 24hr. RBC 
mean values generally increased significantly. The 
mean WBC count increased significantly (p<0.01) for 
all doses and at all durations. Neutrophil count 
significantly changed at 24hr in the rat blood. Mean 
eosinophil count significantly (p<0.01) increased at 
6hr and 12hr, whereas it decreased significantly 
(p<0.05) for the low (5mM) and high doses (50mM) 
at 24hr. Lymphocyte count decreased statistically 
(p<0.01) at 6hr and 24hr, whereas for the low dose 
(5mM) at 24hr increased significantly, but showed no 
significant change in lymphocyte count at 12 hr. 
Platelet count changed significantly at all durations 
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such as at 6hr for 10mM dose, at 12hr for 10mM, 
25mM and 50mM, and for all doses at 24hr. Platelet 
counts in rat blood decreased however at 6hr for 25 & 
50mM and at 12hr for the 5mM dose. 
 
 
Table 1. Results of biochemical analysis of rats in control and carbendazim (CAR) treated groups. 
 
Parameter Duration Control 5mM CAR 10mM CAR  25mM CAR   50mM CAR 
  6hr 6.10 ± 0.191 5.92 ± 0.273** 6.21 ± 0.100** 6.10 ± 0.129 6.10 ± 0.106 
12hr 6.10 ± 0.161 5.50 ± 0.209** 5.25 ± 0.174** 5.10 ± 0.250** 5.20 ± 0.193** 
Protein 
(g/dL) 
24hr 6.21 ± 0.086 6.00 ± 0.093** 5.90 ± 0.081** 5.70 ± 0.077** 5.60 ± 0.112** 
 6hr 43.66 ± 2.37 44.00 ± 1.18 46.00 ± 1.15 46.00 ± 1.06 47.00 ± 2.01 
12hr 45.00 ± 2.55 39.00 ± 1.69 43.00 ± 2.29 48.00 ± 1.87 49.00 ± 1.57 
Cholesterol 
(mg %) 
24hr 43.00 ± 1.31 62.00 ± 2.59** 74.00 ± 2.17** 75.00 ± 2.97** 77.00 ± 2.12** 
  6hr 38.0 ± 2.64 45.0 ± 4.54 40.0 ± 2.88 46.0 ± 4.28 50.0 ± 3.43 
12hr 48.0 ± 3.95 46.5 ± 4.01 38.0 ± 2.47** 43.0 ± 2.58 46.0 ± 4.06 
Urea 
(mg %) 
24hr 28.0 ± 2.67 25.0 ± 1.82 15.0 ± 1.09** 20.0 ± 1.00 16.0 ± 0.894** 
 6hr 12.4 ± 0.165 14.5 ± 0.159** 14.8 ± 0.230** 15.0 ± 0.134** 16.0 ± 0.335** 
12hr 12.7 ± 0.193 13.1 ± 0.143** 14.0 ± 0.214** 14.4 ± 0.256** 15.0 ± 0.278** 
Uric acid 
(mg/dL) 
24hr 11.0 ± 0.157 13.6 ± 0.188** 14.0 ± 0.428** 14.3 ± 0.332** 14.5 ± 0.348** 
  6hr 1.20 ± 0.103 1.67 ± 0.060** 0.99 ± 0.073** 0.77 ± 0.044** 2.54 ± 0.085** 
12hr 1.3 ± 0.082 1.09 ± 0.06** 1.19 ± 0.053** 1.22 ± 0.042** 2.45 ± 0.093** 
Glucose 
(mg/ml) 
24hr 0.6 ± 0.038 0.95 ± 0.055** 0.98 ± 0.072** 1.35 ± 0.057** 0.868 ± 0.058** 
 6hr 3.06 ± 0.152 2.70 ± 0.211** 3.60 ± 0.173**    3.10 ± 0.201 3.15 ± 0.180 
12hr 3.20 ± 0.173 3.30 ± 0.180 3.20 ± 0.198 2.90 ± 0.274** 3.20 ± 0.198 
Albumin 
(gm %) 
24hr 3.50 ± 0.222 4.00 ± 0.219** 3.20 ± 0.169** 2.90 ± 0.203** 3.10 ± 0.268** 
 6hr 0.3 ± 0.044 0.33 ± 0.051** 0.31 ± 0.044** 0.2 ± 0.036** 0.3 ± 0.044 
12hr 0.4 ± 0.044 0.41 ± 0.057** 0.5 ± 0.057** 0.4 ± 0.068 0.51 ± 0.057** 
Creatinine       
(mg /dL) 
24hr 0.5 ± 0.068 0.51 ± 0.068* 0.56 ± 0.057** 0.6 ± 0.081** 0.7 ± 0.077** 
 6hr 10.0 ± 0.421 10.5 ± 0.413** 11.0 ± 0.339** 10.8 ± 0.345** 10.9 ± 0.340** 
12hr 11.0 ± 0.461 8.90 ± 0.348** 10.4 ± 0.383** 11.0 ± 0.338 9.90 ± 0.358** 
Calcium 
(mg/dL) 
24hr 11.1 ± 0.340 9.60 ± 0.392** 9.90 ± 0.330** 13.8 ± 0.349** 8.71 ± 0.415** 
 6hr 7.00 ± 0.536    7.00 ± 0.296 8.10 ± 0.270**    7.00 ± 0.300 8.60 ± 0.413** 
12hr 6.00 ± 0.264 6.50 ± 0.316**    5.93 ± 0.359  6.80 ± 0.251**    6.20 ± 0.371 
Phosphorous 
(mg/dL) 
24hr 6.00 ± 0.115 7.00 ± 0.262** 6.30 ± 0.194** 6.00 ± 0.269 7.60 ± 0.318** 
Values are mean ± SEM from 6 rats in each group. Statistically significant at p≤0.05 = * and p≤0.01 = **. 
Discussion 
Individuals may get exposed to carbendazim through 
occupation and or consumption of food products. 
Primary exposure for general human population will 
be from residues of benomyl and carbendazim used 
on food crops. Very limited research related to the 
effects of carbendazim on tissues (such as brain, 
heart, liver, kidney and testis) as well as on 
biochemical and heamatological parameters had been 
done earlier on mammals. The present study, 
therefore investigate the acute effect of carbendazim 
on male rat tissues from a biochemical, hematological 
and histopathological points of view.  
Decrease in serum total protein and albumin were 
noted  with  in  male  rats. Decrease in protein content  
 
could be due to a decrease in the rate of protein 
synthesis. Rats fed 50, 150, 450 and 1350ppm 
carbendazim in the diet for 13 weeks, yielded urine 
and blood chemistry within normal range. Female rats 
that received 1350ppm carbendazim however 
exhibited reduction of total protein content [3]. In 
another study, carbendazim administered daily to rats 
at 0, 150, 300 and 600mg/kg/day by gavage for 15 
weeks, decreased the serum total protein at lower 
dose levels [4]. The increased amount of albumin 
showed at 6 and 24hr duration. Albumin content 
synthesized by the liver – most often transports or 
binds drugs or chemical. So the increase in the 
amount of albumin may be explained by carbendazim  
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treatment [4]. Cholesterol level increased in the serum 
due to liver and kidney damage. An elevated amount 
of serum cholesterol was observed in dogs fed with 
500mg carbendazim/kg for 1 year or longer [13]. 
Similarly, carbendazim administered orally to male 
rats (Rattus rattus) for the 15 weeks, caused an 
increase of albumin, glucose, creatinine and 
cholesterol levels [4]. 
 
Table 2. Results of haematological analysis of rats in control and carbendazim (CAR) treated groups. 
 
Parameter Duration Control 5mM CAR 10mM CAR 25mM CAR 50mM CAR 
  6hr 11.3 ± 0.73 12.9 ± 0.45 15 ± 0.34** 12.9 ± 0.28 12.9 ± 0.57 
12hr 12.3 ± 0.60 15.6 ± 0.37** 13.4 ± 0.38 15.6 ± 0.36** 12.5 ± 0.26 
HB 
(gm/dL) 
24hr 12 ± 0.72 12.5 ± 0.38 12.5 ± 0.51 14.6 ± 0.78* 12.5 ± 0.58 
  6hr 2.6 ± 0.146 2.1 ± 0.123* 2.5 ± 0.131 2.2 ± 0.106 2.4 ± 0.093 
12hr 4.15 ± 0.211 3.2 ± 0.129** 2.5 ± 0.157** 3.4 ± 0.121* 2.4 ± 0.106** 
RBC 
(mill / cu.mm) 
24hr 4.8 ± 0.233 2.3 ± 0.152** 2.1 ± 0.251** 4.6 ± 0.288 2.8 ± 0.229** 
  6hr 5.25 ± 0.271 5.8 ± 0.146** 6.7 ± 0.107** 8.2 ± 0.146** 5.5 ± 0.100** 
12hr 6.2 ± 0.313 8.27 ± 0.108** 9.4 ± 0.173** 9.9 ± 0.151** 9.0 ± 0.111** 
WBC 
(x 10³/cu.mm) 
24hr 5.4 ± 0.196 9.4 ± 0.124** 8.1 ± 0.159** 7.9 ± 0.111** 7.4 ± 0.147** 
  6hr 63 ± 1.06 59 ± 1.77 67 ± 1.73 68 ± 2.35 70 ± 1.57 
12hr 64 ± 1.80 63 ± 2.20 67 ± 1.87 66 ± 2.88 65 ± 1.94 
N (%) 
 
24hr 61 ± 1.82 45 ± 2.16** 70 ± 1.59 71 ± 1.69* 67 ± 2.22 
  6hr 2 ± 0.258 2 ± 0.577 3 ± 0.447** 3 ± 0.258** 3.5 ± 0.577** 
12hr 4 ± 0.577 4 ± 0.577 5 ± 0.577** 5 ± 0.447** 4 ± 0.577 
E (%) 
24hr 5 ± 0.577 4 ± 0.577* 4.5 ± 0.516 5 ± 0.577 3 ± 0.577** 
  6hr 35 ± 0.577 37 ± 0.930 30 ± 1.29** 28 ± 0.930** 27 ± 1.15** 
12hr 32 ± 1.77 35 ± 2.11 32 ± 1.06 27 ± 0.93 29 ± 1.39 
L (%) 
24hr 31 ± 0.577 49 ± 1.06** 26 ± 1.23** 20 ± 1.00** 30 ± 1.15 
  6hr 3.3 ± 0.166 3.3 ± 0.141 3.5 ± 0.169** 3.1 ± 0.121** 3.2 ± 0.100** 
12hr 3.3 ± 0.129 3.1 ± 0.159** 3.6 ± 0.216** 3.5 ± 0.191** 3.5 ± 0.159** 
Platelet 
(lakhs/cu.mm) 
24hr 2.8 ± 0.177 3.2 ± 0.123** 3.8 ± 0.123** 4.1 ± 0.180** 5.6 ± 0.148** 
Values are mean ± SEM from 6 rats in each group. Statistically significant at p≤0.05 = * and p≤0.01= **. 
 
Blood serum glucose levels increased statistically 
significant at 50mM doses of carbendazim treated rats 
at all duration. The increase of glucose level may be 
attributed to disruption of glucose intake and use by 
cells [3]. The decrease in urea content may be due to 
decreased amino acid metabolism as a result of 
carbendazim toxicity [4]. The amount of uric acid was 
however noted to be alongwith increased, serum 
creatinine level in rats fed carbendazim. It is however 
known that increase of creatinine occured with renal 
failure [14]. Serum calcium content increased at 6hr, 
and decreased at 12 and 24 hr, while the phosphorous 
level was also noted to be increased in the serum.  
As for the hematological analysis, carbendazim 
caused increase in hemoglobin content, white blood 
cells, eosinophil count and platelet count in a dose 
related manner but decreased red blood cell, 
lymphocyte and neutrophil counts. The decrease in 
red blood cells may indicate a disruption of 
erythropoiesis or an increase in destruction of red 
blood cell. The latter in more probable since increase 
in hemoglobin content is noted alongside decrease in 
RBC counts. Similarly, it was reported that 
carbendazim caused a dose dependent decrease in 
RBC and lymphocyte values in rats [4]. Increase in 
the WBC count indicated enhanced immune capacity 
and indicated the eosinophilia by the increase in 
eosinophil numbers. 
 
Conclusion 
The invest data suggests that at low dose elicited 
toxic effects in the various organs of rat through 
affecting biochemical and hematological parameters 
resulting in histopathological changes. Use of this 
pesticide in countries where pesticides were widely 
used without regulation may cause health hazard at 
various levels to nontarget organisms, including that 
of human beings. 
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